Sunday, February 15, 2009

Bad Steroid Arguments Make Baby Jesus Cry

I'd been doing my best to bury my head in the sand over the whole steroid brouhaha when Howard Sinker recapped the past week in steroid madness on his Section 220 blog. Sinker's approach, as many folks' have been, was largely to shake his head over the seeming insanity of the parties involved and hope it all faded away very soon.

For some reason, though, Sinker's essay struck me very differently than other steroid madness rants have of late; I'm guessing it's a juxtaposition of arguments over steroids in baseball with arguments over the economic stimulus package just finishing its path through Congress. I've finally come to realize that the steroid debate in baseball isn't a medical debate or even a debate about sports -- it's a political debate. And like many political debates, the people involved who seek to take advantage of the situation for their own political gain are using really shoddy arguments to back up their position. If there's anything we've learned from the new Obama administration lately, it's that the only good way to defeat shoddy arguments is to get out there and push your own better arguments, so here's my attempt to do this on the steroid issue:

- Bud Selig claims he's considering reinstating Hank Aaron as all-time home run leader.

This is stupid, but not precisely the way Sinker says it is. Sinker is right when he says that "baseball fans and others" decide how to interpret the raw statistics of baseball (and 'others' probably refers primarily to the members of the BBWAA who vote on Hall of Fame inductions), but the statistics themselves can be shaped by MLB to some degree -- take the most famous case prior to this one, Roger Maris's 1961 season. Maris's 1961 season has been described as having an 'asterisk' in the record books, but that's not strictly true -- what is true is that for years the record books looked like this:

Most home runs, single season, 154 games: Babe Ruth (60)
Most home runs, single season, 162 games: Roger Maris (61)

Who was your 'home run king'? It all depended on how you wanted to look at it. Interpreting the stats, as Sinker notes, is a fan's and writer's game.

Based on this example, though, it's hard to understand how Selig expects to be able to put Aaron back on the top of the career home run list:

Most home runs, career, non-steroid user: Henry Aaron
Most home runs, career, steroid user: Barry Bonds (soon to be Alex Rodriguez, et al)

Not only is this not really a baseball distinction, it's a distinction that ultimately can't be ended -- at what point do we decide that baseball players aren't using steroids anymore and thus can be legitimately considered for statistical enshrinement? First, go hit 750 homers, then piss in this cup?

The more likely way in which Selig would attempt to reinstate Aaron as the 'official' home run king is to put Bonds, A-Rod, et al on some kind of permanent ineligible list, a la Pete Rose (which of course begs the question -- if the Commissioner has the authority to strike ineligible players' statistics from the baseball record, why is Pete Rose still baseball's all-time hits leader?) This, too, is a really stupid idea, and can be illustrated with a simple TwinsGeek-like 'player A/player B'

A - .346/915; 101 HR, 1599 R, 1464 RBI, 455 SB over 16 seasons
B - .356/940; 54 HR, 873 R, 785 RBI, 202 SB over 13 seasons

Though player B was a slightly better hitter by BA/OPS, and the difference in their playing time was a bit larger than the 16/13 seasons comparison would suggest (player A had approximately 8300 plate appearances in his career, while player B had approximately 5630), that seems to me to speak to player B's tendency toward injury rather than any knock on player A. In addition, player A hit over .400 three times in his career, led his league in hitting once, led his league in slugging five times (though they didn't keep track of that in his day), and led his league in home runs twice. Player B hit over .400 just once, never led his league in batting average, never led his league in home runs, and led his league in slugging just once. Player A is in the Hall of Fame, Player B is not.

Yet few baseball fans would likely recognize Player A as Ed Delahanty, who was elected by the Veterans Committee in 1945. His plaque notes that he went six-for-six twice in his career and hit four homers in a game once. Even once you know his name, you probably don't know much about him.

You might not recognize Player B by his numbers, but you'll recognize his name: Joe Jackson, placed on baseball's 'permanently ineligible' list by then-Commissioner Kenesaw Mountain Landis in 1920.

Selig doesn't have the power to remove Bonds's or Rodriguez's statistics from baseball's record, any more than Landis could remove Jackson's statistics or Bart Giamatti could remove Rose's statistics. Because of this, I'd expect that any attempt to restrict 'official' sanction for Bonds and Rodriguez (and others) will have exactly the opposite effect that Selig wants -- Bonds and Rodriguez and whomever else is held off the top of the career homers list will, for at least some portion of baseball's fandom, become the most popular players of all time, just as currently there are groups agitating for the removal of Rose and Jackson from the banned list.

- The 'cheating' argument.

Sinker quotes Roy Oswalt in an unfortunate rant about how Rodriguez's stats shouldn't count, because Oswalt himself has never taken Performance Enhancing Drugs (PEDs), and Rodriguez's 'cheating' could have cost Oswalt wins and thus money in his contract.

Well, for starters I can see why Oswalt is pissed: a check of baseballreference.com's Play Index shows that Rodriguez is a career 3-for-7 against Oswalt, with all three hits being for extra bases (two doubles and a homer) and three RBI. On the other hand, that's less than 10 plate appearances, and if 10 plate appearances can cost a pitcher millions of dollars on his contract, then baseball is a far more exacting game than I was ever aware of, economically at least. I might be a bit more sympathetic if Oswalt were bitching about Pedro Feliz (.452/1275 with 2 HR and 8 RBI in 32 career PAs vs Oswalt) or even Neifi Perez (.407/851 in 28 career PAs), but I find it hard to get my dander up over 9 plate appearances in an entire big-league career.

More to the point, I don't believe Oswalt when he says he's never used PEDs. Has he never had a cortisone shot? As Will Leitch points out in his book "God Save The Fan", cortisone is an injectable steroid just like the bad-boys use. And back in 2004, Oswalt admitted that he took at least three cortisone shots to deal with an injury in his rib cage that otherwise would have prevented him from pitching. The essay in Leitch's book talks about Scott Rolen, who got a cortisone shot prior to the 2006 World Series against the Tigers and helped the Cardinals win. But was there an outcry from Tiger fans over Rolen's 'cheating' costing them the World Series? Nope.

The argument seems to go like this: cortisone is OK because it doesn't let you do anything you wouldn't otherwise have been able to do when you were healthy, whereas HGH, the cream, and such gives you abilities you didn't previously have.

That sounds good, but there's not a lot of empirical evidence to back up that assertion, from either end.

Sure, we have anecdotal evidence relating to Ken Caminiti's shocking MVP season, Bonds's single-season HR record year, and Mark McGwire's 1998 run at Maris's record. But by those standards, anybody could be a steroid user -- I have a friend who makes a compelling argument that Kirby Puckett took steroids from 1986-1987, at just about the time that Jose Canseco was singing their praises while a youngster with the Oakland A's. After all, Puckett had hit just 13 homers in over 200 minor league ballgames, then hit four in his first two full seasons with the Twins before hitting 31 in 1986 and 28 in 1987. Then, at an age where players' power tends to slowly increase, Puckett's seemed to vanish, as he dropped to 24 homers in 1988 and just 9 in 1989, despite having nearly identical numbers of plate appearances in those three seasons: Puckett had 668 PAs in 1987, 691 in 1988, and 684 in 1989. Only then did Puckett's home run totals begin to increase again, at a seemingly age-appropriate rate that led to a new career norm of about 20 homers per year. Unless we're willing to kick Kirby Puckett out of the Hall of Fame, we clearly can't rely on just anecdotal evidence.

Problem is, we don't have a lot of empirical evidence linking steroids and actual baseball performance, and what evidence we do have tends to say that the impact of steroids in baseball is far less than the alarmists claim. Thomas Boswell writes that it's suspicious that Rodriguez's home runs leapt by 12 or so per year after moving from Seattle to Texas, even though Texas is a notoriously easier park in which to hit homers. Boswell ignores that Rodriguez moved to Texas for his age 25 season, and played there through his age 27 season, which tend to be the peak seasons of a player's career. Taking the development factor into account, JC Bradbury looks at the numbers and claims that steroids were worth about one extra homer per year in the seasons in which Rodriguez says he was taking them. (And harkening back to the Kirby Puckett example: Puckett's 1986 home run breakout occurred in his age 26 season.)

What we do have is a lot of empirical evidence showing that steroids can increase muscle mass, and then a leap of faith that says that players with bigger muscles must be able to hit the ball harder, ergo more homers. While I have little doubt that this is probably true in the aggregate -- the more players taking steroids, the more homers will be hit -- and that this hypothesis does fit the 'home run era' of turn-of-the-century baseball, I have a hard time reconciling that with the evidence we have of the people who were actually suspended for steroid use during that time.

For instance, when MLB announced ten players who'd violated the new steroid policy back in 2005, the only one of those players with any significant major-league success was Twins set-up reliever Juan Rincon. (Rincon's reward for his allegedly steroid-fueled 2004? A two-year contract worth about $1 million, or less than half of what the Twins have reportedly offered Luis Ayala.) About half of the players on the list didn't even have any major league service time, which immediately suggests that, if steroids are this magic potion that makes you a superstar, why these guys were still languishing in AA and AAA?

Or look at the famous Mitchell Report. There are a number of high-profile names on the list, not just Roger Clemens and Barry Bonds, but reading through the actual report makes it seem as though the high-profile players on the list weren't looking at steroids as a way to make them greater, but to hang onto big-league jobs they already had. In that sense, most players' apparent image of steroids matches the experience that Mark McGwire had taking androstenedione in 1998 -- prior to 1998, McGwire had a few seasons that seemed to suggest that he could hit 60+ homers if he was able to play a full season (in 1995, he hit 39 homers in 422 plate appearances, while in 1996, he hit 52 in 548 plate appearances). If he could simply stay in the lineup for 650 plate appearances or so, the home run title would be all but locked up. Well, in 1997 he hit 58 homers in 657 plate apparances, but the impact was masked because he split his production between leagues -- two-thirds of the season in Oakland and a third in St. Louis. Then in 1998, McGwire famously hit 70 homers -- and did it in 681 plate appearances. Given his move from Oakland to St. Louis, much of that increase in rate could be attributed simply to a change in ballparks (in his 1997 split-season, McGwire hit 34 homers in 433 PAs in Oakland, just about his career rate to that point, but pounded 24 in 224 PAs in St. Louis, slightly better than the rate he had in all of 1998). What 'andro' did for McGwire is basically what cortisone did for Scott Rolen and Roy Oswalt -- allowed them to continue playing at a high level of performance when their physical condition would normally either prevent them from playing at all or would at least degrade their level of performance. If that's a PED, then it's a PED for McGwire and Rolen...and Oswalt, who really shouldn't be throwing stones from the porch of his glass house.

If you combine 'home runs are going up because of steroids' with 'nobody really good is being busted for steroid use', you get a result that absolutely cries out for a conspiracy theory. And while we do know that it's true that high-tech steroid designers are deliberately engineering their steroids to evade current testing technology, it's also true that these steroids are being taken by way more than just baseball players -- it's actually hard to argue that baseball is the driving force behind these 'designer steroids' when baseball is so late to the party on steroid enforcement -- the International Olympic Committee and the World Anti-Doping Agency are way ahead of baseball both on enforcement and testing of athletes for PEDs, and not just artificial PEDs, either.

But where there are conspiracy-minded people, all it takes is one bit of evidence to get the engines whirling.

- The 'anonymous testing' brouhaha

The first official steroid test in MLB occurred during the 2003 season, thanks to an addendum added to the Basic Agreement between the league and the player's union in late 2002. An awful amount of misinformation about MLB's steroid testing regime could be clarified by referencing the publically available document: (the joint drug testing program is listed as Attachment 18)

Myth: The player's union was responsible for running the anonymous 2003 testing program.

Fact: According to the agreement, administration of the entire program, from 2003 and beyond, was placed in the hands of a Health Policy Advisory Committee (HPAC), consisting of four people: two doctors, one named by MLB and the other by the union, and two lawyers, one named by MLB and the other by the union. In the event of a deadlock, the two doctors were given authority to name a fifth member of the committee solely for the purpose of breaking the deadlock.

Myth: The union failed to destroy the anonymous test samples as they should, and MLB was thus able to get ahold of the samples and identify the players who failed tests.

Fact: First, the union wasn't in charge of the testing process, HPAC was. There's some evidence that HPAC turned the records over to the union for destruction once their own work was done, but as noted by Gene Orza, lead attorney for the player's union, the destruction was delayed by the receipt of a federal subpoena. MLB hasn't released the names of the players involved in the positive tests, and still cannot because of the agreement between MLB and the union (see below).

Second, because of possible issues with legal over-the-counter supplements creating 'false positives' for the test, the testing process had a unique requirement -- all players (not just those who failed the initial test) would be tested twice; the second test would occur at least five but not more than seven days after the first test. At the first test, players would be told that they should stop taking OTC supplements until after taking the second test. If more than 10% of the positive tests in the first batch showed up negative in the second, HPAC would be responsible for advising the Commissioner's Office and the union on how to adjust the testing program to ensure that players taking legal supplements were not unfairly punished by failing drug tests. This would help explain why, even though the testing occurred during the 2003 season, the actual records and results were not turned over to the union for destruction until November.

Myth: The anonymous testing was a gimmick that MLB had to agree to in order to get the union to agree to testing at all.

Fact: The agreement between MLB and the union (on page 167 to be precise) says this:

The confidentiality of the Player’s participation in the Program is essential to the Program’s success. Except as provided in Section 8, the Office of the Commissioner, the Association, HPAC, Club personnel, and all of their members, affiliates, agents, consultants and employees, are prohibited from publicly disclosing information about the Player’s test results, Initial Evaluation, diagnosis, Treatment Program (including whether a Player is on either the Clinical or Administrative Track), prognosis or compliance with the Program.


The problem is that the federal government seized the 104 positive tests from 2003 as potential evidence in the federal investigation into the Bay Area Laboratory Co-operative (BALCO). The reason should be pretty obvious -- BALCO was being investigated for selling Schedule III controlled substances illicitly (that is, directly to users without a doctor's prescription). A record of a sale of a steroid to a user without a prescription, then a record that the user failed a steroid test, would make very convincing evidence that BALCO was violating the U.S. Controlled Substances Act.

That prosecution is still banging through the court system today, however, partly because of federal screw-ups. For instance, the search warrant used by the Feds to seize the test results only named the ten players being investigated for their connections to BALCO, meaning that the government really only had authority to take those ten players' tests. It hasn't yet been explained why the government got all the failed tests.

It's also true that the union has been fighting a lot harder than the Commissioner's Office has to try to keep the names of the players who failed the tests out of the public record; that's why you're seeing Don Fehr and Gene Orza making these announcements and not Bud Selig or any of his lieutenants.

Myth: The union delayed testing in 2004 so that they could warn players of the upcoming tests.

Orza has been accused of this twice by unnamed sources in the Commissioner's Office -- he's denied the allegations both times. That in and of itself doesn't mean the allegations are untrue, but Orza's point is a good one: if these allegations were true, one would expect there to be evidence, and thus far none has appeared.

Penalty-based testing was delayed in 2004 at the request of the union, but the union asked for the delay in order to alert the 104 members whose tests were seized by the government. MLB agreed to the delay.

In short, if more people would actually read the primary sources involved in this news, there'd be a lot less misinformation out there. Another example of misinformation is Sinker's own suggestion that MLB could do something similar to what they did in 1986 with seven players who were being suspended for using illegal drugs. The problem with this alternative is that MLB and the union, when renegotiating the 2003 agreement into the current agreement, spelled out the allowable penalties for players who fail penalty-based testing, and Sinker's suggestion isn't included. (That's not to say that Sinker's suggestion is a bad one, just that it's not something in the existing agreement. Frankly, I have no confidence in Bud Selig's judgment over what's legal or moral, so I'd prefer to leave all of that in the hands of collective bargaining anyway.)

One last point for those who think this aggressive, 'zero-tolerance' policy on steroids is a good thing; there's reason to believe that the steroid policy may have directly influenced the Twins competitiveness in 2005.

Recall that first-baseman Justin Morneau had just earned the starting job in mid-season of 2004 and Twins fans were looking forward to seeing what a full season of Morneau as the first-baseman would look like offensively. Then during the off-season, Morneau suffered a bout of pleurisy. Despite the old-timey name, pleurisy is still a reasonably common condition, often occurring as a complication to rib injury or to bacterial or viral respiratory infection; it's an inflammation of the membranes that surround the lungs, and can be dry (without fluid buildup) or wet (with fluid buildup). Treatment for pleurisy generally consists of treating the primary condition, then treating the inflammation with anti-inflammatory drugs.

Well, there are basically two types of anti-inflammatory drugs: non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin and ibuprofen, and corticosteroids. Corticosteroids are significantly stronger than ibuprofen -- if you've ever spent time around an asthma patient, the inhaler they use when they feel an attack coming on contains a fast-acting corticosteroid. However, it's possible (though certainly not a given), because the high pitch of anti-steroid fever following the 2004 season, Morneau may have chosen to treat his pleurisy with non-steroidal pain relievers/anti-inflammatory drugs, extending his recovery time and keeping him at less than 100% effectiveness throughout the 2005 season (still by far Morneau's worst as a professional). And of course, given the reaction to Rincon's failed drug test during that season, it's hard to say that Morneau's decision was the wrong one -- sure, we all want to see our favorite players back on the field and 'playing through pain', but how many non-Twins fans would have given Morneau the benefit of the doubt when he says he was taking the steroid for pleurisy rather than to mask a PED?

Looks like the steroid discussion just got more complicated.

Wednesday, February 11, 2009

Three Hundred Words About Luis Ayala (and Twins Geek)

The signing will please contrarians immensely, because that 2008 ERA is such a deliciously large target, and the truth is that he wasn't better than that. He was exactly that.


That comes from TwinsGeek, the grandfather of Twins bloggers, and a more obvious call-out I haven't seen in a long time. (The name of my blog when I wrote for the Geek on his TwinsTerritory.com site was "Contrarian Bias".)

I wouldn't say I'm pleased with the signing necessarily, though -- I'm a bit more contrarian even than that. For starters, both the Geek and Gleeman seem to think that the Ayala signing guarantees him a spot in the bullpen, but I don't think that's a given: for starters, the link from Gleeman's analysis to the Strib story discussing the signing doesn't quote anybody in the Twins organization saying what they expect Ayala's role to be. (The only comment from a Twins exec is Bill Smith saying, in effect, "No comment.") The quote about Ayala competing for the setup job is from Ayala's agent, who of course believes that's what his client is doing to do, because that's why he convinced his client to sign the contract (even though, as far as we can tell, he hasn't actually...y'know...signed a contract yet. See below.)

Yes, Ron Gardenhire has a tendency to favor veterans over young players, but he's got a stronger tendency to favor players who've produced for him to players he doesn't know well who struggle, regardless of age (see how quickly Gardy dropped Phil Nevin from the lineup in 2006, or Bret Boone in 2005).

Also, the Twins have been known to sign veterans in the off-season, invite them to spring training, and then release them before the season:

2005: Andy Fox, Eric Munson, C.J. Nitkowski
2006: Darrell May, Ryan Glynn
2007: Randy Choate
2008: Randy Kiesler

Of course, you probably don't remember many if any of these guys -- I sure didn't, until I looked them up on baseball-reference.com.

Oddest of all, there doesn't seem to be any indication that Ayala has actually been signed: the most bizarre of the stories out there was posted to MLB.com and penned by Doug Miller with the headline "Twins add Ayala to relief corp", which begins with the following sentence:

The Twins made a move toward shoring up their bullpen Friday, signing right-hander Luis Ayala to a one-year, $1.3 million contract, according to the Minneapolis Star-Tribune.

And ending with this sentence:

Twins GM Bill Smith declined comment, keeping with team policy of not discussing negotiations.

Huh? If the player signed a contract, aren't you done negotiating with him? (By the way, the Strib story referenced by Miller? That's the Christiansen story linked to by Gleeman, which says only that the Twins and Ayala have reached an agreement.

So much for sports journalism.)

The Geek seems to think Ayala's troubles in 2008 are a mystery, since he still struck out plenty. Gleeman seems to think Ayala was unlucky, which is normally an argument I'd agree with -- in this case, though, even Ayala's fielding-independent ERA for 2008 posts at 4.47, which isn't a mark that most Twins fans will feel comfortable with from a set-up reliever.

I'll agree with Gleeman that Ayala's numbers make him look to be about the fifth man deep in a good AL bullpen, and not a setup-guy at all; what I'll disagree with is Gleeman's assertion that Ayala's very presence in spring training will make it hard for Phil Humber or Bobby Korecky to make the opening day roster. I think if Ayala has an outstanding spring he'll be on the roster and might even be the Twins first set-up man of the season, but if his spring goes poorly (and he's starting it out with a stint in the World Baseball Classic, pitching for his native Mexico), I think the Twins brass, Gardenhire included, would find it a lot easier to cut a $1.3 million veteran with no history with the franchise than a guy who's been in the organization since 2003 (Korecky was the PTBNL in the Eric Milton trade back in 2003 in which the Twins also acquired Carlos Silva and Nick Punto), or a guy who was in a package of players for arguably the best starting pitcher in Twins history (Humber).

Oh well, I guess this is actually a lot closer to a thousand words than three hundred. Just goes to show you how you can get carried away about even the smallest things in life. Perhaps I'd have been better off simply showing a picture.

Tuesday, February 3, 2009

Dreaming Big, Living Small

Reader Marv makes a very reasoned point in the last post regarding Jason Kubel:

It seems to me that the obvious question is, "What would Adam Dunn have cost?". If Kubel's SLG % goes up then he was probably the right choice...Difficult to assess at this point whether this was a good signing or a missed opportunity.


Marv's point is dead-on; it's going to be really hard to tell before the start of the 2011 season whether the Kubel deal was a good one or a bad one on its own merits. Plus, it's not very easy to actually measure the opportunity costs involved in signing Kubel over signing or trading for an alternative, especially when the Twins have seemingly larger needs than replacing their league-average outfielder-DH.

But there's another way to look at the signing, and since we've still got about a week left in Hot Stove League action, let's go ahead and dream big:

Instead of signing Jason Kubel to a 3-year, $12 million contract, what if the Twins had signed Manny Ramirez to a 3-year, $62 million contract?

OK, I know, for starters the Twins would never offer this kind of contract. The closest they've ever come to offering this kind of contract was the five-year, $100 million contract they reportedly offered Johan Santana -- and that Santana reportedly turned down. And Santana was still young with the potential of being effective at the end of the five year deal -- Ramirez is about to turn 37, which means by the time the Twins would be able to wriggle out of the deal, Ramirez would be pushing 40 and might not even be an active player anymore. The deal would be a humongous risk for a franchise for which the phrase 'risk-averse' is an absurd understatement.

Even if they offered it, Ramirez might not accept it: Ramirez has already rejected a deal from the Dodgers reportedly structured similarly to the Kubel deal, but worth $45 million over two years rather than $7 million, with a third team option year. There's evidence that Ramirez isn't so hung up over the lack of a guaranteed third year as he is the lack of a guaranteed fourth year, which to a club like the Twins looks absolutely insane.

Those aren't the points. The point is, if the Twins spent an extra $50 million on Manny Ramirez over Jason Kubel for the next three seasons, would it be worth it?

Begin with the obvious:

- Jason Kubel's best season in the major leagues was 2008, when he hit .272/806 with a park-adjusted OPS+ of 118.
- Manny Ramirez's worst season, among 15 seasons with at least 60 plate appearances, was when he hit .269/878 with a park-adjusted OPS+ of 124 as a 22-year old rookie. His next-worst season was in 2007, when he hit .296/881 with a park-adjusted OPS+ of 126 as an allegedly disaffected 35-year old with the Red Sox, in a season where the Sox won the World Series.

It's not impossible to imagine that Kubel could finish 2009, or the entire 2009-2011 period, with better offensive numbers than Manny Ramirez, but nothing in either player's history suggests that it's likely. Ramirez's career average hitting line is .314/1004, and he hit better than that when adding in both his Boston and LA stats in 2008 (.332/1031). Kubel would need to have the best seasons of his career at the same time that Ramirez is having the worst seasons of his. Again, not impossible, but if you tried to set up a betting line in Vegas, you'd have to shut it down for lack of interest in Kubel.

I pointed out in the previous post that Fangraphs posts numbers that suggest that Kubel was worth about $2 million to the Twins in 2008; the same measures suggest that Ramirez was worth a combined $28.3 million to his teams in 2008.

Let's move on to the not-so-obvious:

- Manny Ramirez, from 2005-2007, was among the worst regular left-fielders in baseball defensively, amassing UZR/150 ratings of -23.7, -26.4, and -25.0 in each of those three seasons. His career UZR/150 in left is a very poor -12.7.
- Kubel, in 2008, had a UZR/150 in left field of -46.6, and has a career UZR/150 in left that's even worse than Ramirez's: -16.3.

So sure, Kubel DH's two-thirds of the time and Ramirez famously doesn't want to DH -- but putting Ramirez's glove in left would actually be arguably better than putting Kubel's out there.

- Kubel, in 2008, collected a Win Probability Added rating of .94, meaning he added about one win to the Twins performance over what someone of 'typical' performance might have done in his shoes. His .94 WPA in 2008 comprises his entire career WPA of .91 and slightly more.

- Ramirez, in 2008, collected a Win Probability Added rating of 7.57 split between his two ballclubs, meaning he added between seven and eight wins to his clubs' performance over a 'typical' performer. Though this total was the highest of his career, his career WPA of 52.16 still dwarfs even his top season.

Hard to add anything to that comparison.

- The most optimistic projection of Kubel's 2009 season comes from the Bill James Baseball Handbook published by Baseball Info Solutions; it projects Kubel as hitting .282/837 next season with 22 HR in 569 PAs.

- The most pessimistic projection of Ramirez's 2009 season comes from Sean Smith's CHONE system; it projects Ramirez as hitting .290/941 with 32 HR in 565 PAs.

The difference between these two projections -- the most optimistic Kubel projection and the most pessimistic Ramirez projection -- still has Ramirez ahead by 30 runs created -- and thus approximately three wins -- in a nearly identical number of at-bats. That's the best-case comparison in Kubel's favor that's still within reason and predictable; unreasonable would involve either Kubel or Ramirez hitting 60+ HRs and thus having a fluke season, unpredictable would involve either Kubel or Ramirez suffering a season-ending injury in May.

The last point here begins to hint at the real issue underlying this analysis: what is a win worth, and how much should you pay for it? There are basically three ways to look at the situation:

1. The Academic View

Those who've studied the issue of what's called marginal win cost generally come to three conclusions: first, winning the first 50 games is cheap, since any team can bring up a bunch of league-minimum AAA players and expect to win 50+ games during the regular year; second, winning the last 50 games is ridiculously if prohibitively expensive, since so few teams have actually won 112+ games it stands to reason that factors beyond mere payroll are responsible for teams that perform that well; third, that within the 62 games in the middle of this analysis, some teams do better than others in how much they pay for these 'marginal wins'.

It's assumed in this view that you do best by paying the lowest marginal win cost, though it's difficult to translate that into a concrete 'how-to'; marginal win studies can do a great job of pointing out how efficient the Twins and A's are at turning cash into wins, but the closest they get on how to accomplish the feat is to say 'find young players who can play and get them onto your roster while you don't have to pay them anything'. Easier said than done, of course.

2. The Fan's View

Those who follow the game often seem to fall into a mode of thinking where no amount of money is too much to pay for a championship; Yankee fans in particular seem especially guilty of subscribing to this view, aided and abetted by their longtime GM, George Steinbrenner.

Unfortunately, the 'how to' in this situation also seems muddled, in the sense that most fans seem eager to spend money on 'big name' players, using the theory that the more famous a player is, the better he is and thus the more likely your team will win as a result. Ask a Yankee fan if the big-name acquisitions the club made from 2002-2006 really helped their ballclub, then ask why they think the 2009 acquisitions will be any better. (Be prepared to duck.)

3. The Team's View

There's ample evidence to suggest that actual major league teams, particularly the successful ones at buying marginal wins, don't look at the situation as one where they try to maximize the number of wins they buy for a given payroll, but rather where they try to meet a target number of wins for the least amount of payroll. (This precise sort of analysis is the focus of a chapter in Michael Lewis's "Moneyball", specifically "The Science of Winning an Unfair Game".) Nearly any press release of the Terry Ryan-Bill Smith Twins will show you the same kind of thinking at work; the team isn't trying to maximize their win total as much as they're trying to reach a specific win goal while leaving their options open financially.

Ramirez over Kubel would be a clear win in the eyes of paradigm #2; if the Twins did sign Ramirez to a free-agent contract, those local writers who didn't immediately pan the signing as coddling to a huge ego would likely argue that the Twins should not only be the favorites to win the AL Central, but the World Series as well -- after all, the club has won a lot of games with players like Michael Cuddyer and Nick Punto; how many more wins can they get now that they have a 'real' hitter?

Paradigm #1 wouldn't tell us anything that we couldn't predict ourselves; the Twins would be increasing both their win total as well as their marginal win cost. The Twins would merely go from being one of the most efficient teams at turning money into wins to being middle-of-the-pack, still ahead of clubs like Seattle, Baltimore, and Texas who continue to have huge payrolls and disappointing on-field performance.

Paradigm #3 though, would win the day -- if the front office really believes that their current roster can win 90 games in 2009, and they think that 90 wins should win or at least contend for the division title and/or the Wild Card, what incentive do they have to spend an extra $50 million over three years to up that total to 93 or more? Why dump the big money and take a big risk on Manny Ramirez, with all the baggage that implies, when you can spend a reasonable amount of money on a guy who fits into your system, never complains, and can still help you get to where you want to go? Just like a game of baseball counts the same whether you win by one run or ten, the playoffs still largely look the same if you win your division by two games or by fifteen. What are the extra wins really getting you, except more risk?

It's killing for a fan to realize this -- the ballclub isn't going to roll the dice on a big-name acquisition because they simply don't see the need to take that kind of risk. But that's ultimately why Jason Kubel, warts and all, is a better player for the Twins than Manny Ramirez. They know him, he knows them, and they both have a good idea where they're headed.

So yes, the failure to go out and get an Adam Dunn or a Garrett Atkins or even a Manny Ramirez is a wasted opportunity; it's just not an opportunity worth paying for, in the long run.